Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Journal of Immunology Research|June 9, 2016
Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung CancerKoichi Takayama, Shunichi Sugawara, Yasuo Saijo, et al.
Cancer Science|July 28, 2015
Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 alleleShinjiro Sakamoto, Satoko Matsueda, Shinzo Takamori, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2020
Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trialMasanori Noguchi, Gaku Arai, Shin Egawa, et al.
Cancer Science|February 9, 2017
Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11+ or -A33+ alleleShinjiro Sakamoto, Satoko Matsueda, Shinzo Takamori, et al.
Oncology Reports|November 17, 2020
A randomized phase III trial of personalized peptide vaccination for castration‑resistant prostate cancer progressing after docetaxelMasanori Noguchi, Kiyohide Fujimoto, Gaku Arai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2015
An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based ChemotherapyMasanori Noguchi, Kazumasa Matsumoto, Hirotsugu Uemura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responsesTakashi Mine, Yuji Sato, Masanori Noguchi, et al.
International Journal of Oncology|April 3, 2020
Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patientsShigetaka Suekane, Shigeru Yutani, Akira Yamada, et al.
Cancer Biology & Therapy|October 12, 2010
Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccinationMasanori Noguchi, Takashi Mine, Nobukazu Komatsu, et al.
Pageof 10